Cidara Thera (NQ: CDTX )

1.680 USD -0.130 (-7.18%)

Streaming Delayed Price Updated: 4:00 PM EDT, Oct 15, 2021 Add to My Watchlist

Price and Volume

Volume	667,637
Open	1.820
Bid (Size)	1.690 (2)
Ask (Size)	1.770 (14)
Prev. Close	1.810
Today's Range	1.670 - 1.860
52wk Range	1.460 - 3.270
Shares Outstanding	49,506,268
Dividend Yield	N/A

Intraday 1 Week 1 Month 3 Month 1 Year

Top News

More News

Cidara Therapeutics to Present New Data for Rezafungin at TIMM Congress

September 29, 2021

Cidara Therapeutics to Present New Data for Rezafungin at IDWeek 2021

September 27, 2021

Performance

YTD	-18.45%	-18.45%
1 Month	-19.62%	-19.62%
3 Month	+6.33%	+6.33%
6 Month	-18.84%	-18.84%
1 Year	-45.45%	-45.45%

More News

Cidara Therapeutics to Participate in Two Upcoming Investor Conferences

September 07, 2021

Cidara Therapeutics to Host Research and Development Day

September 02, 2021

Cidara Therapeutics Appoints Preetam Shah, Ph.D., MBA, as Chief Financial Officer and Chief Business Officer, and Shane Ward as Chief Legal Officer and Corporate Secretary

September 01, 2021

Cidara Therapeutics and Mundipharma Announce Completion of Enrollment in the Phase 3 ReSTORE Trial of Rezafungin for the Treatment of Candidemia and Invasive Candidiasis

August 17, 2021

Cidara Provides Corporate Update and Reports Second Quarter 2021 Financial Results

August 12, 2021

Cidara Therapeutics to Participate in the 2021 Wedbush PacGrow Healthcare Conference

August 05, 2021

Cidara Therapeutics to Present New Data for Rezafungin at the International Society for Human and Animal Mycology (ISHAM) Asia Congress

July 27, 2021

12 Health Care Stocks Moving In Friday's Pre-Market Session

October 08, 2021

12 Health Care Stocks Moving In Thursday's After-Market Session

October 07, 2021

Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.